These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 13198244)

  • 21. Current concepts of beryllium poisoning.
    VAN ORDSTRAND HS
    Ann Intern Med; 1951 Dec; 35(6):1203-17. PubMed ID: 14895001
    [No Abstract]   [Full Text] [Related]  

  • 22. Beryllium poisoning; its increasing clinical importance and a report of a case of pulmonary granulomatosis due to beryllium.
    DUNN FL; PRATT PT
    Nebr State Med J; 1949 Jun; 34(6):217-20. PubMed ID: 18129969
    [No Abstract]   [Full Text] [Related]  

  • 23. Occupational beryllium poisoning in New Jersey with special reference to its incidence, diagnosis and compensation.
    MARTLAND HS; BRODKIN HA; MARTLAND HS
    J Med Soc N J; 1948 Jan; 45(1):5-14. PubMed ID: 18904233
    [No Abstract]   [Full Text] [Related]  

  • 24. CALIFORNIA bureau finds no beryllium poisoning among 34 workers in the neon sign industry.
    Occup Health (Wash D C); 1952 Apr; 12(4):52. PubMed ID: 14911135
    [No Abstract]   [Full Text] [Related]  

  • 25. Role of chelating agents and antioxidants in beryllium induced toxicity.
    Johri S; Shukla S; Sharma P
    Indian J Exp Biol; 2002 May; 40(5):575-82. PubMed ID: 12622205
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chemical approaches to the treatment of beryllium poisoning.
    SCHUBERT J; ROSENTHAL MW
    AMA Arch Ind Health; 1959 Feb; 19(2):169-78. PubMed ID: 13616738
    [No Abstract]   [Full Text] [Related]  

  • 27. Environmental studies in plants and laboratories using beryllium; the acute disease.
    EISENBUD M; BERGHOUT CF; STEADMAN LT
    J Ind Hyg Toxicol; 1948 Sep; 30(5):281-5. PubMed ID: 18881082
    [No Abstract]   [Full Text] [Related]  

  • 28. Pathologic aspects of acute pneumonitis and pulmonary granulomatosis in beryllium workers.
    VORWALD AJ
    Occup Med (Chic Ill); 1948 Jun; 5(6):684-9. PubMed ID: 18113770
    [No Abstract]   [Full Text] [Related]  

  • 29. Redox process is crucial for inhibitory properties of aurintricarboxylic acid against activity of YopH: virulence factor of Yersinia pestis.
    Kuban-Jankowska A; Sahu KK; Niedzialkowski P; Gorska M; Tuszynski JA; Ossowski T; Wozniak M
    Oncotarget; 2015 Jul; 6(21):18364-73. PubMed ID: 26286963
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Berylliosis; acute pneumonitis and pulmonary granulomatosis of beryllium workers.
    MACHLE W; BEYER E; GREGORIOUS F
    Occup Med (Chic Ill); 1948 Jun; 5(6):671-83. PubMed ID: 18113769
    [No Abstract]   [Full Text] [Related]  

  • 31. Acute dermatitis and pneumonitis in beryllium workers; review of 406 cases in 8-year period with follow-up on recoveries.
    DeNARDI JM; VAN ORDSTRAND HS; CARMODY MG
    Ohio State Med J; 1949 Jun; 45(6):567-75. PubMed ID: 18127900
    [No Abstract]   [Full Text] [Related]  

  • 32. Acute inhalation toxicity of beryllium; the enhancing effect of the inhalation of hydrogen fluoride vapor on beryllium sulfate poisoning in animals.
    STOKINGER HE; ASHENBURG NJ; DeVOLDRE J; SCOTT JK; SMITH FA
    Arch Ind Hyg Occup Med; 1950 Apr; 1(4):398-410. PubMed ID: 15433489
    [No Abstract]   [Full Text] [Related]  

  • 33. Risk of beryllium sensitization in a low-exposed former nuclear weapons cohort from the Cold War era.
    Mikulski MA; Leonard SA; Sanderson WT; Hartley PG; Sprince NL; Fuortes LJ
    Am J Ind Med; 2011 Mar; 54(3):194-204. PubMed ID: 21298695
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aurintricarboxylic acid protects against cell death caused by lipopolysaccharide in macrophages by decreasing inducible nitric-oxide synthase induction via IkappaB kinase, extracellular signal-regulated kinase, and p38 mitogen-activated protein kinase inhibition.
    Tsi CJ; Chao Y; Chen CW; Lin WW
    Mol Pharmacol; 2002 Jul; 62(1):90-101. PubMed ID: 12065759
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of time-dependent recovery from beryllium toxicity following chelation therapy and antioxidant supplementation.
    Johri S; Shrivastava S; Sharma P; Shukla S
    Indian J Exp Biol; 2004 Aug; 42(8):798-802. PubMed ID: 15573530
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aurintricarboxylic acid decreases proliferative potential of SKOV3 and MCF7 human carcinoma cells.
    Fraifeld V; Seidman R; Sagi O; Muradian K; Wolfson M
    Anticancer Res; 2001; 21(3B):1975-8. PubMed ID: 11497286
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aurintricarboxylic acid is an inhibitor of mu- and m-calpain.
    Posner A; Raser KJ; Hajimohammadreza I; Yuen PW; Wang KK
    Biochem Mol Biol Int; 1995 Jun; 36(2):291-9. PubMed ID: 7663433
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aurintricarboxylic acid inhibits endothelial activation, complement activation, and von Willebrand factor secretion in vitro and attenuates hyperacute rejection in an ex vivo model of pig-to-human pulmonary xenotransplantation.
    Kim HK; Kim JE; Wi HC; Lee SW; Kim JY; Kang HJ; Kim YT
    Xenotransplantation; 2008; 15(4):246-56. PubMed ID: 18957047
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lack of efficacy of aurintricarboxylic acid and ethacrynic acid against vaccinia virus respiratory infections in mice.
    Smee DF; Hurst BL; Wong MH
    Antivir Chem Chemother; 2010 Apr; 20(5):201-5. PubMed ID: 20413827
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effect of adrenocorticotrophic hormone on tissue distribution and acute toxicity of beryllium].
    WHITE MR; FINKEL AJ; SCHUBERT J
    Proc Soc Exp Biol Med; 1952; 80(4):603-4. PubMed ID: 12983356
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.